| Date | Title | Description |
| 11.03.2026 | Учимся предсказывать конверсию в опросах. Часть 2 | Вот и мы задумались, как же это сделать
Всем привет! На связи Айкович Ульяна и команда Pathway. Месяц назад мы опубликовали первую часть, в которой рассказали о нашем эксперименте по предсказанию конверсии в прохождение опросов. Сегодня мы ... |
| 10.04.2025 | Runa Capital: Europe’s open source scene punches above Its weight in AI and Infrastructure | This week international venture capital firm Runa Capital released the latest quarterly Runa Open-Source Startup (ROSS) Index, a regularly updated ranking of the top-trending open-source startups.
The annual report ranks 20 top-trending ope... |
| 23.10.2024 | Продуктовый дизайн: спрос растет, а специалистов не хватает. Анализируем рынок | Эксперты из крупнейших компаний России объясняют, что происходит в продуктовом дизайне прямо сейчас и где пролегает тонкая грань между дизайнером и продактом.
В России продолжает увеличиваться спрос на дизайнеров разных специализаций, говор... |
| 17.04.2024 | Intel’s deeptech accelerator announces its seventh cohort | Intel Ignite, Intel's global startup accelerator program for early-stage deeptech startups, has announced the 10 startups who make up its seventh cohort, which will convene in Munich.
Deeptech is now the largest VC funding category in Europ... |
| 16.10.2023 | Which French B2B Startups Are Transforming the European Business Landscape? | France is a European economic powerhouse, known for its diverse landscapes and rich history. But it is not just tourist landmarks and exquisite cuisine that place it in the limelight; it is also a vibrant tech startup hub. Today, we are del... |
| 22.08.2023 | Pathway bring real-time value to logistics through machine unlearning | There's a problem in machine learning you'll likely start hearing more about. No, it's not hallucinations. It concerns what happens when data that machines learn from is found to be false, inaccurate, or becomes outdated. Imagine the conseq... |
| 06.12.2022 | Polish-French deeptech startup Pathway receives $4.5M in a pre-seed round | Polish-French deeptech startup Pathway receives $4.5M in a pre-seed round
06 December, 2022, 13:51
Mariia Denysiuk --> --> --> -->--> --> --> --> --> --> --> --> -->
The Paris-based framework for re... |
| 26.07.2017 | The second coming of consumer genomics with 3 predictions for 2018 | A brief history of human genomics
Genomics is defined by the WHO as the study of all parts of an organism’s genes and their functions whereas genetics is the study of heredity or how single genes are passed between generations. The Human Ge... |
| 03.03.2017 | Invitae CEO wants to democratize genetic testing | A smaller competitor of Myriad believes that the only way the true value of genomics testing can be yielded is if it becomes mainstream. For that, two things must happen — costs must continually come down and the addressable market has to e... |
| 28.02.2017 | Mayo Clinic startup OneOme pitches user-friendly pharmacogenomics | The OneOme pharmacogenomic test kit
Investigational drugs in the U.S. are required to undergo ‘ADME‘ pharmacology testing to characterize Absorption, Distribution, Metabolism and Excretion.
The problem is that individuals process drugs diff... |
| 05.12.2016 | App combining genomics, fitness and diet highlights nutrigenomics trend | DNAFit also promotes itself to Ancestry.com and 23andMe customers — two companies also in the genetic testing business (Ancestry.com has a genetic testing division, AncestryDNA).
Earlier this year Pathway Genomics and IBM Watson announced t... |
| 18.05.2016 | What is ‘smart’ nutrition, and how will it revolutionize food? | Economists envision humans as rational, cost-benefit-maximizing individuals, a position which sometimes makes it difficult to understand the insane dietary choices many people make. Humanity’s legendary dietary mistakes — which include a ki... |
| 20.01.2016 | These are the key players in the home health testing market | Source: Kalorama Information
Direct-to-consumer laboratory testing is on the rise, as consumers become more educated and proactive about their own health. The market’s expected to grow past $350 million by 2020 – a significant increase over... |
| 10.01.2016 | The competition: Who is Illumina’s new $100M startup, Grail, up against in cancer liquid biopsy screening? | But other companies have been touting advances in liquid biopsy screening for some time now. This is hardly the first gander at a pan-cancer test, right? San Diego-based Pathway Genomics, for instance, announced this past summer that it had... |
| 09.01.2016 | The definitive guide to the J.P. Morgan Healthcare Conference | “Sentiment will be weary, but not funeralesque,” said Les Funtleyder, portfolio manager of E Squared Asset Management and author of the book “Health-Care Investing.” “Normally, sentiment is extremely bullish at JPMorgan, but once every few ... |
| 06.01.2016 | Pathway Genomics Nabs $40M to Expand Precision Medicine via Genetic Testing | San Diego, CA-based Pathway Genomics, a clinical laboratory facilitating precision medicine through genetic testing and mobile healthcare applications has raised over $40 million in Series E funding. This brings the total investment into Pa... |
| 30.12.2015 | Pathway Genomics pays more than $4M to settle kickback allegations from DOJ | Pathway Genomics has voluntarily ended its physician reimbursement program.
“While genomic testing is a valuable and relatively recent medical tool, when specialized laboratories pay for referrals they aren’t breaking any new ground but rat... |
| 25.09.2015 | Pathway Genomics responds to FDA’s concerns on liquid biopsy test | The FDA said, after all, in its warning letter that the Detect test didn’t have the appropriate regulatory approvals or clearances. Pathway Genomics made a splash in the news earlier this month with news that it had the first liquid biopsy ... |
| 24.09.2015 | Pathway Genomics gets FDA warning letter for its liquid biopsy test | Pathway has posted a white paper on its site that details the rationale for why its liquid biopsy test is sufficiently validated. But the FDA writes:
It is unclear how the literature that you cited, addressing the presence of circulating tu... |
| 10.09.2015 | Pathway Genomics launches first liquid biopsy test for cancer | “We’re the first to market – this is the first test of its kind,” Pathway Genomics chief commercialization officer Ardy Arianpour told MedCity News. Indeed, there are multiple players in the liquid biopsy game – including San Diego’s Trovag... |
| 08.08.2015 | From a heart patient’s use of the Apple Watch to Pathway Genomics’ app: 5 must-read stories from MedCity News this week | 1. Heart patient: Apple Watch got me in and out of hospital fast
Virginia resident Ken Robson, 64, had been visiting his son in the San Diego area in mid-June. “I had been noticing that I had been feeling weak and lightheaded,” he said. He ... |
| 10.07.2015 | Morning Read: Could remote monitoring help Novartis persuade payers to reimburse for new heart drug? | TOP STORIES
Novartis got FDA approval for new heart medication this week, amidst concerns that its price tag will dissuade insurers from reimbursing it. But in an interview with The Wall Street Journal, Novartis CEO Joe Jimenez (pictured) m... |
| 24.06.2015 | Study: Customers of commercial genomic testing services understand results more than expected | Although 23andMe’s testing is now approved, it was previously under scrutiny based on a warning from the Food and Drug Administration in 2013 when concerns about customers misunderstanding test results could lead to mismanagement of medicat... |
| 13.11.2014 | Pathway Genomics Receives Investment from IBM Watson Group | Pathway Genomics Corporation, a San Diego, California-based clinical laboratory that offers genetic testing services globally, received an investment from IBM Watson Group.
The company has raised more than $80m since inception.
Founded in 2... |
| 12.11.2014 |
Pathway Genomics Lands Investment From Google
| San Diego-based Pathway Genomics has scored an investment from Google, the two said Wednesday, as part of an investment out of IBM's Watson Group. Financial terms of the investment were not disclosed. According to the companies, the investm... |
| 15.10.2014 | How IBM's Watson could be good for your health | Technology giant IBM has been talking about the value of its Watson software, which processes great quantities of text and then provides answers to people’s questions on the fly, for many industries, including media, mining, retail, and sec... |
| 15.10.2014 | How IBM's Watson could be good for your health | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Technology giant IBM has been talking about the v... |
| 06.03.2014 | Founders Fund has a fresh $1B to spend. Here’s a look at its healthcare picks | As of late, it’s been doing quite a bit in the digital health and genetics space. Here’s a look at the health-focused companies it’s invested in through its angel and venture funds
This list was compiled based on the fund’s website and news... |
| 05.01.2012 | Eight technologies for a healthier 2012 | Welcome to 2012 and a new list of New Year’s resolutions — a list that likely includes some variation on adopting a healthier lifestyle. Thanks to the acceleration of technology, fulfilling your resolutions this time around may be easier th... |
| 11.05.2010 | Morning Read: What makes a healthcare expert? | Wellpoint goes on the offensive: 2010 is shaping up to be an absolutely brutal year in the court of public opinion for Indianapolis-based insurer Wellpoint. See stories about its revoking the policies of breast cancer patients and its “math... |
| - | App combining genomics, fitness and diet highlights nutrigenomics trend | Genomics and big data analytics have become part of a growing fitness trend to personalize workout and nutrition regimens over the years. Critics have called into question the usefulness of these tests and note many lack scientific validati... |
| - | Pathway Genomics launches first liquid biopsy test for cancer | Direct-to-consumer genetic testmaker Pathway Genomics is the first to market in launching a liquid biopsy test that screens for multiple cancers. That means that from a single blood test it will be able to detect whether otherwise healthy p... |
| - | Pathway Genomics gets FDA warning letter for its liquid biopsy test | The Food and Drug Administration has sent Pathway Genomics a warning letter that expresses concern over its new liquid biopsy test for cancer, and that it’s being marketed with a direct-to-consumer bent. Indeed, the FDA has called the diagn... |
| - | Pathway | “Pathway is the programming framework which handles streaming data updates for you.” |
| - | Invitae CEO wants to democratize genetic testing | We are in the early days of precision medicine but it is on the back of widespread gene testing that promise of this approach of treating diseases stands.
And there are plenty of companies offering some kind of gene testing – on the tumor D... |
| - | Pathway Genomics responds to FDA’s concerns on liquid biopsy test | San Diego liquid biopsy testmaker Pathway Genomics recently received a letter from the Food and Drug Administration warning against its CancerIntercept Detect diagnostic. The test, regulators say, may be misleading, is being in appropriatel... |
| - | From a heart patient’s use of the Apple Watch to Pathway Genomics’ app: 5 must-read stories from MedCity News this week | Yesterday’s MedHeads featured Chris Seper, Stephanie Baum, Meghana Keshavan and special guest David Kroll, a regular contributor to Forbes, who will also moderate the precision medicine panel discussion at MedCity CONVERGE next month. Kroll... |
| - | Mayo Clinic startup OneOme pitches user-friendly pharmacogenomics | The OneOme pharmacogenomic test kit
Investigational drugs in the U.S. are required to undergo ‘ADME‘ pharmacology testing to characterize Absorption, Distribution, Metabolism and Excretion.
The problem is that individuals process drugs diff... |
| - | The second coming of consumer genomics with 3 predictions for 2018 | As healthcare venture investors, my colleagues Adam Seabrook, Hailey Hu, and I identify disruptive trends at the intersection of healthcare and technology and back companies that are pursuing those trends. Occasionally, albeit rarely, we co... |
| - | These are the key players in the home health testing market | Source: Kalorama Information
Direct-to-consumer laboratory testing is on the rise, as consumers become more educated and proactive about their own health. The market’s expected to grow past $350 million by 2020 – a significant increase over... |
| - | Morning Read: Could remote monitoring help Novartis persuade payers to reimburse for new heart drug? | TOP STORIES
Novartis got FDA approval for new heart medication this week, amidst concerns that its price tag will dissuade insurers from reimbursing it. But in an interview with The Wall Street Journal, Novartis CEO Joe Jimenez (pictured) m... |
| - | The definitive guide to the J.P. Morgan Healthcare Conference | Ah. Another January, another J.P. Morgan Healthcare Conference — where this year’s biggest biopharma deals are just a cocktail and a handshake away. As swaths of C-suite execs descend upon San Francisco, here’s an overview of some of the id... |
| - | Morning Read: What makes a healthcare expert? | Highlights of the important and the interesting from the world of healthcare:
What makes a healthcare expert? The Health Care Renewal blog isn’t happy about the media portraying leaders of healthcare organizations who have no clinical exper... |
| - | Study: Customers of commercial genomic testing services understand results more than expected | For the average person without a science or healthcare background, genetic testing results would be, seemingly, difficult to understand. But that doesn’t seem to be the case, if a new study is anything to go by. That’s good news for compani... |
| - | Founders Fund has a fresh $1B to spend. Here’s a look at its healthcare picks | The rumors were true – kind of: The Founders Fund has been out raising a massive amount of cash for a fifth fund, but it’s not $750 million as originally thought. It’s $1 billion, the fund said today.
Most known for backing Facebook, Spotif... |
| - | Pathway Genomics pays more than $4M to settle kickback allegations from DOJ | It’s not just the Food and Drug Administration that’s peeved with Pathway Genomics‘ marketing tactics: The San Diego diagnostics company will pay more than $4 million to settle kickback claims levied by the U.S. Department of Justice – admi... |
| - | The competition: Who is Illumina’s new $100M startup, Grail, up against in cancer liquid biopsy screening? | On the eve of this year’s J.P. Morgan Healthcare Conference, Illumina made a much-hyped announcement: With $100 million in Series A funding, it just launched Grail, a diagnostics startup that is developing a pan-cancer blood test. The circu... |
